VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BLLN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BLLNBillionToOne, Inc.
$97.50$4.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBLLNP/E History

BLLN logoBillionToOne, Inc. (BLLN) P/E Ratio History

Deep Value

Trading at 106.1x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2025–2026

Current P/E (TTM)
106.1x
-85% vs 5Y avg
5Y Avg P/E
698.2x
Median 193.5x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
106.1x
Min117.4xMedian193.5xMax2311.9x
TTM EPS$0.92
Price$97.50
Earnings Yield0.94%
EPS Growth (1Y)103.4%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of November 18, 2026, BillionToOne, Inc. (BLLN) trades at a price-to-earnings ratio of 106.1x, with a stock price of $97.50 and trailing twelve-month earnings per share of $0.92.

The current P/E is 85% below its 5-year average of 698.2x. Over the past five years, BLLN's P/E has ranged from a low of 117.4x to a high of 2311.9x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 25.0x, BLLN trades at a 324% premium to its sector peers. The sector includes 249 companies with P/E ratios ranging from 0.0x to 184.2x.

Relative to the broader market, BLLN commands a significant premium over the S&P 500 median P/E of 21.5x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BLLN DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

BLLN Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
106.1vs25.0
+324%
Above Sector
vs. S&P 500
106.1vs21.5
+393%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 103% EPS growth (1Y)

BLLN P/E vs Peers

Reference and Genetic Labs peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
ILMN logoILMNIllumina, Inc.
$31B34.98.24+171%Best
PGNY logoPGNYProgyny, Inc.
$3B32.74.89+14%
CDNA logoCDNACareDx, Inc
$4B31.9--143%
TMO logoTMOThermo Fisher Scientific Inc.
$255B36.017.04+7%
DHR logoDHRDanaher Corporation
$159B36.8--5%
A logoAAgilent Technologies, Inc.
$49B33.82.30Best+3%
BIO logoBIOBio-Rad Laboratories, Inc.
$10B9.4Lowest-+143%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

BLLN Historical P/E Data (2025–2026)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2026 Q3Sep 30 2026$106.44$0.91117.4x-83%
FY2026 Q2-$119.98$0.62193.5x-72%
FY2026 Q1-$78.94$0.46169.9x-76%
FY2025 Q4Dec 31 2025$81.84$0.042311.9x+231%

Average P/E for displayed period: 698.2x

Export Data
Consensus & Technical Research Suite
Open BLLN Terminal

BLLN Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

1+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

BLLN — Frequently Asked Questions

Quick answers to the most common questions about buying BLLN stock.

What is BLLN's P/E ratio?

BillionToOne, Inc. (BLLN) trailing twelve-month P/E ratio is 106.1x, based on TTM diluted EPS of $0.92. The 5-year average P/E is 698.2x and the historical range spans 117.4x to 2311.9x.

Is BLLN stock overvalued or undervalued?

BLLN trades at 106.1x P/E, below its 5-year average of 698.2x. At the 0th percentile of its historical range (117.4x–2311.9x), the stock is priced at a discount to its own history.

Is BLLN stock expensive?

No, BLLN is not expensive on a historical basis. The current P/E of 106.1x is below the 5-year average of 698.2x and sits at the 0th percentile of its valuation range.

What is BLLN's historical P/E range?

Over the past 5 years, BLLN's P/E ratio has ranged from 117.4x to 2311.9x, with a median of 193.5x and an average of 698.2x. The current P/E of 106.1x places the stock at the 0th percentile of this range. Full historical data spans 2025–2026.

How does BLLN's P/E compare to the S&P 500?

BLLN trades at 106.1x P/E versus the S&P 500 median of 21.5x. The 393% premium to the market typically reflects higher expected earnings growth or quality.

How does BLLN's valuation compare to Healthcare peers?

BillionToOne, Inc. P/E of 106.1x compares to the Healthcare sector median of 25.0x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is BLLN's PEG ratio?

BLLN PEG ratio is N/A, based on a P/E of 106.1x and EPS growth of 103.4%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is BLLN's earnings yield?

BLLN earnings yield is 0.94%, the inverse of its 106.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

BLLN P/E Ratio History (2025–2026)

Quarterly valuation multiple from closing price and trailing EPS

Current117.4x
Period Avg698.2x
Range117.4x - 2311.9x
Change-95%
4 quartersDec 31, 2025 - Sep 30, 2026